Connect with us
European Gaming Congress 2024

Artificial Intelligence

AXA Hong Kong launches the first ‘AXA Chronic Disease Management Programme’

Published

on

AXA collaborates with 4 medical institutions to launch the ‘AXA Chronic Disease Management Programme', including CUHK Medical Clinic, Hong Kong Diabetes Specialist Centre, HKSH Medical Group and Virtus Medical Group.

 

According to a recent survey conducted by AXA Hong Kong, comprising 1,000 Hong Kong people, it is deduced that more than one-third of those surveyed have been diagnosed with chronic diseases in which this proportion increased to over 50% in the 45-60 age group[1]. Observed chronic diseases do not solely trouble the aged, AXA Hong Kong have been bringing customers with innovative health management solutions. Furthermore, government’s latest statistics also reveal that the proportion of chronic disease patients aged 15-24 years increased from 9.2% to 12.4% in 3 years[2]. Taking diabetes mellitus as an example, it is estimated that this affects one person in every 10 in Hong Kong, and for one in every 5 diabetic patients, the disease occurs before the age of 40[3]. Furthermore, the age-standardised prevalence of gout increased continuously in 10 years, reaching 1.4% in 2016[4]. Indeed the cost of chronic disease management is often as burdensome as that of critical diseases, the expenditure involved is too high to be disregarded.

‘AXA BetterMe’, a one-of-a-kind platform launched by AXA Hong Kong in 2018, strives to promote overall physical and mental wellbeing by offering a unique suite of diseases management programmes and health protection and diseases prevention solutions. This year, AXA Hong Kong announced the ‘AXA Chronic Disease Management Programme’ (Programme), collaborating with CUHK Medical Clinic, Hong Kong Diabetes Specialist Centre, HKSH Medical Group and Virtus Medical Group. The programme targets different chronic diseases, including diabetes mellitus, hypertension, hypercholesterolemia and gout, and provides an all inclusive service that include outpatient medical consultations, annual comprehensive complication, dietitian consultation, and more.

Dr. Alexander Chiu, Medical Director, Health and Employee Benefits, AXA Hong Kong and Macau, said, “The demand for insurance for chronic diseases cannot be ignored. AXA Hong Kong has reformed its core concept of insurance and expanded the coverage of its products to cope with changes in society since 2018, helping customers improve their health. The collaboration with CUHK Medical Clinic, Hong Kong Diabetes Specialist Centre, HKSH Medical Group and Virtus Medical Group aims at helping chronic disease patients in a more effective way, with proper consultation and solutions provided by professional medical organisations. We are looking forward to working with more of these reputable medical institutions, and to providing more personalized and flexible plans and products, to overcome the challenges of the market and to help our customers prepare a healthy body and mind to embrace the future.”

All ‘AXA Wiseguard Pro Medical Insurance’ eligible customers[5] are entitled to particiate in ‘AXA Chronic Disease Management Programme’ with 12-month of medical service. The participants are allowed to choose one of the following institutions as their service provider: CUHK Medical Clinic, Hong Kong Diabetes Specialist Centre, HKSH Medical Group and Virtus Medical Group. Under the Programme, the participants will receive up to four out-patient medical consultations by a registered medical practitioner, one dietician consultation and one annual comprehensive complication assessment by an endocrinologist or specialist, and nurse communication.

Advertisement
Stake.com

To provide the best healthcare to customers, a registered medical practitioner will be assigned to support each participant throughout the entire Programme journey. The registered medical practitioner will conduct an initial medical consultation, as well as follow-up appointments. A personal health target will be set according to the condition of each individual, including electrocardiogram (ECG), blood test for blood pressure and/or HbA1c, for a more effective health management routine. For those who successfully reach their goal, a 10% premium discount[6] will be given against their eligible basic plan in recognition of the efforts which the customer has striven to achieve.

Meanwhile, the expenditure of daily medication and self-financed drugs could be a huge financial burden. In view of this, this Programme offers an option of medication from a pre-agreed list or alternative medication at a special discount. It covers up to 52 weeks of treatment/dosage[7] which provides a more comprehensive protection to the customer.

Initiatives under ‘AXA BetterMe’ include the ‘Quit Smoking Incentive Programme’, ‘AXA Diabetes & Three-Highs Management Programme’, ‘Health Collaboration Programme’ with Mannings and also the ‘Mind Health’ promotes employee wellness. AXA Hong Kong will put forth the “payer to partners” promise by developing more innovative solutions with renowned medical institutions under ‘AXA BetterMe’, empowering customers to lead a healthy and happy life.

 

SOURCE AXA Hong Kong

Advertisement
Stake.com

Artificial Intelligence

APIX and RBI Join Forces to Drive Financial Innovation Through HaRBInger 2024 Hackathon

Published

on

apix-and-rbi-join-forces-to-drive-financial-innovation-through-harbinger-2024-hackathon

SINGAPORE, June 21, 2024 /PRNewswire/ — APIX, the leading global collaborative innovation platform for financial institutions and fintechs across over 90 countries, today announced its partnership with the Reserve Bank of India (RBI) to host the prestigious HaRBInger 2024 hackathon. This landmark collaboration aims to bring together the brightest minds from around the world to develop cutting-edge solutions that enhance the security and inclusivity of the financial ecosystem.

Under the overarching themes of Combatting Fraud and Financial Inclusion for the Differently-abled, the hackathon challenges participants to tackle four critical problem statements focused on real-time fraud detection, ensuring transaction anonymity, identifying mule accounts, and empowering the visually impaired in financial transactions.
“At APIX Platform, we are thrilled and proud to once again partner with Reserve Bank of India (RBI) for HaRBInger,” shares Umang Moondra, CEO of APIX. “Reserve Bank of India (RBI) has led from the front in driving innovation in the financial services sector, and HaBRInger 2024’s focus on critical challenges related to fostering security, integrity, transparency, trust and inclusivity in digital transactions, is a testament to the leadership role that they play.”
As a trusted platform utilised by major banks and regulators worldwide, APIX is uniquely positioned to empower innovators and accelerate their journey toward bringing innovative ideas to life. Leveraging innovative technologies such as AI/ML, APIs, Data Analytics, and more, HaRBInger 2024 participants will have the opportunity to create solutions that drive meaningful change and leave a lasting impact on the financial services industry.
The hackathon welcomes individuals, teams, and enterprises from diverse backgrounds and geographies to participate, offering a platform to showcase their skills on a global stage. With exciting prizes up for grabs, including INR 40,00,000 (~USD 48,000) for the winner in each problem statement category and a special prize of INR 20,00,000 (~USD 24,000) for the best all-woman team, the opportunities are substantial.
Registration for HaRBInger 2024 started on June 7, 2024, and will unfold in four exciting phases on the APIX Platform: screening of entries, shortlisting for solution development, solution development with mentoring and support, and the selection of winners.
Don’t miss this opportunity to collaborate with like-minded innovators, gain exposure to industry leaders, and shape the future of finance on the APIX Platform.
For media inquiries or additional details about HaRBInger 2024, please contact [email protected].
For more information and to register now, visit HaRBInger 2024 at: https://hackolosseum.apixplatform.com/h1/harbinger2024
About APIX:
APIX is a collaborative innovation platform for fintechs and innovators across 90+ countries, empowering Financial Institutions to accelerate their innovation journey. 
Major banks, insurers, and regulators in the world use APIX to rapidly discover, test, and evaluate solutions by running comprehensive innovation programs, which include innovation challenges and hackathons. 
Ideas are everywhere. Bring the best to the table with APIX. Collaborate to innovate today at www.apixplatform.com.  
Logo – https://mma.prnewswire.com/media/2443613/4773081/01_LOGO_COLOR_WITH_BLACK__MAIN_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/apix-and-rbi-join-forces-to-drive-financial-innovation-through-harbinger-2024-hackathon-302178678.html

Continue Reading

Artificial Intelligence

Maxterial Raises nearly $8 Million in Series A Funding

Published

on

maxterial-raises-nearly-$8-million-in-series-a-funding

Reinforces Position as a Disruptive Force in Material Science Innovation

PLEASANTON, Calif., June 20, 2024 /PRNewswire/ — Maxterial, a technology company dedicated to pioneering advancements in material science including the commercialization of advanced coatings, has announced the successful closure of its Series A funding round, raising nearly $8 million. This milestone underscores Maxterial’s rising influence in disruptive material science technologies and its commitment to reshaping traditional industry norms with dynamic and environmentally responsible solutions.
Led by CEO Dr. Mehdi Kargar and Chief Technology Officer Dr. Amy Haghdoost, Maxterial has pioneered material science advancements for nearly a decade. The company’s lean approach to reaching the product-growth fit stage has garnered widespread acclaim, attracting a range of customers and influential investors, including Peter Thiel’s Breakout Labs, Pierre Omidyar’s UP2398, and corporate innovation leaders like Saint-Gobain and Anglo American.
The Series A funding round, led by Helios Climate Ventures, with participation from global corporation QEMETICA (formerly Ciech), solidifies Maxterial’s position as a leader in climate-conscious innovation. This capital enables Maxterial to accelerate its R&D efforts, including large-scale trials, expand its products, and scale operations in North America and Europe.
“We are thrilled to have secured nearly $11 million to date in equity financing, which reflects the confidence investors have in our vision, our unique go-to-market strategies, and the transformative potential of our technology,” said Dr. Mehdi Kargar, CEO of Maxterial. “This scalable platform fits many markets in urgent need of dynamic, sustainable solutions. Series A funding enables us to drive transformational growth across multiple industries.”
Maxterial replaces environmentally harmful and energy-inefficient processes using Hexavalent Hard Chrome (H-Chrome) with a superior solution that is safe, environmentally friendly, and cost effective at a time when material science startups have struggled to attract investment. The company breaks those cycles by delivering unique synergies that integrate the needs of investors, customers, supply chains, and industry experts with a product and service model that delivers exceptional performance, accelerates change and mitigates risk.
Maxterial has already gained significant initial traction. Ongoing trials in Europe and North America are attracting early adopters eager for cutting-edge solutions. By prioritizing sustainability, performance, and scalability, Maxterial can protect against wear, heat, and corrosion, reduce carbon footprint, and eliminate toxic materials like hexavalent chromium.
“We set out to create a company that delivers exceptional technology and exceptional returns,” notes Dr. Kargar. “As we accelerate our implementation, we want to share our insights and expertise with fellow entrepreneurs, industry leaders, and investors interested in driving positive change.”
For media inquiries, please contact:
Carmen FerrignoChief Marketing Officer, MaxterialPhone: 215.287.3658Email: [email protected]
About Maxterial:Maxterial is a Bay Area technology company dedicated to pioneering advancements in material science, including the commercialization of advanced coatings. Founded in 2015, Maxterial leverages an eco-systemic lean tech approach to develop innovative solutions that protect against wear, heat, and corrosion while reducing carbon footprint and eliminating toxic materials from industrial processes. Maxterial is committed to driving responsible transformation in the material science industry through thought leadership, innovation, and collaboration that inspires others to embrace responsible innovation.
To learn more, visit Maxterial.com
Logo – https://mma.prnewswire.com/media/2440672/Maxterial__Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/maxterial-raises-nearly-8-million-in-series-a-funding-302177099.html

Continue Reading

Artificial Intelligence

Altair Named a Leader in the June 2024 Gartner® Magic Quadrant™ for Data Science and Machine Learning Platforms

Published

on

altair-named-a-leader-in-the-june-2024-gartner-magic-quadrant™-for-data-science-and-machine-learning-platforms

Altair recognized in the report’s Leaders’ Quadrant for Completeness of Vision and Ability to Execute
TROY, Mich., June 20, 2024 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader in computational intelligence, today announced that it has been positioned by Gartner as a Leader in the Magic Quadrant for Data Science and Machine Learning Platforms for its offering, Altair® RapidMiner®. The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute.

According to the report, “Leaders in this market have a mature, refined, and targeted company and platform strategy that incorporates and leverages generative AI (GenAI) to drive their customers’ business value. They see opportunities for leveraging GenAI that other providers may not see or have made significant investments above and beyond standard offerings. They have the capability to innovate at a speed that outperforms other vendors. In addition, they can clearly articulate how they provide value to the multiple types of personas involved in the process of building data science and machine learning models.” 
“We believe being named as a Leader in this latest report validates what we have known for years: Altair has one of the market’s most unique, most comprehensive offerings for data analytics and machine learning,” said James R. Scapa, founder and chief executive officer, Altair. “For us, this placement is also a testament to our unmatched vision, which has defined us since our inception. We are pioneers that define what it means to be at the forefront of technological innovation and computational intelligence. I am incredibly proud of where Altair stands today, and I look forward to the strides we continue to make each day.”
Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players. The research enables you to get the most from market analysis in alignment with your unique business and technology needs.
View a complimentary copy of the Magic Quadrant report to learn more about Altair’s strengths and cautions, among other provider offerings, at https://web.altair.com/gartner-magic-quadrant-for-data-science-and-machine-learning-platforms-2024.
Gartner Disclaimer
Gartner, Magic Quadrant for Data Science and Machine Learning Platforms, Afraz Jaffri, Aura Popa, Peter Krensky, Jim Hare, Raghvender Bhati, Maryam Hassanlou, Tong Zhang, 17 June 2024.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Altair
Altair is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI. Altair enables organizations across all industries to compete more effectively and drive smarter decisions in an increasingly connected world – all while creating a greener, more sustainable future. To learn more, please visit www.altair.com.
Media contacts
Altair Corporate                                           
Altair Investor Relations
Bridget Hagan                                             
Stephen Palmtag
+1.216.769.2658                                         
+1.669.328.9111
[email protected]                       
[email protected]
Altair Europe/The Middle East/Africa
Charlotte Hartmann
+49 7031 6208 0
[email protected]
 
Photo – https://mma.prnewswire.com/media/2444041/Altair_Newsroom_NR_Gartner_MQ_Social__2.jpg
Logo – https://mma.prnewswire.com/media/1421069/Altair_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/altair-named-a-leader-in-the-june-2024-gartner-magic-quadrant-for-data-science-and-machine-learning-platforms-302178198.html

Continue Reading

Trending